Development of the hepatitis C self-management program

Erik J Groessl1, Kimberly R Weingart, Allen L Gifford

  • 1Health Services Research and Development, VA San Diego Healthcare System, San Diego, CA 92161, USA. egroessl@ucsd.edu

Insights

A new Hepatitis C Self-Management Program (HCV-SMP) was developed to help patients with chronic hepatitis C infection manage their condition and improve quality of life. This program uses cognitive-behavioral principles to enhance adherence to treatment recommendations.

Area of Science:

  • Hepatology
  • Public Health
  • Behavioral Science

Background:

  • Chronic hepatitis C infection (HCV) presents a significant global health challenge, particularly impacting underserved populations.
  • Many individuals with HCV face barriers to curative antiviral treatment, necessitating alternative management strategies.
  • Self-management support is crucial for improving health-related quality of life (HRQOL) in patients with chronic conditions.

Purpose of the Study:

  • To describe the development of a novel self-management program tailored for patients with chronic hepatitis C infection.
  • To provide HCV-infected individuals with tools and knowledge to enhance adherence to health recommendations and improve HRQOL.

Main Methods:

  • The Hepatitis C Self-Management Program (HCV-SMP) was developed using a multi-disciplinary approach, integrating scientific literature, patient interviews, and expert clinical feedback.
  • The program utilizes cognitive-behavioral principles and consists of six weekly 2-hour workshop sessions.
  • Session activities include disease-specific education, action planning, and problem-solving strategies.

Main Results:

  • The HCV-SMP is a comprehensive program designed to equip patients with practical skills for managing their chronic hepatitis C.
  • The program's structure facilitates knowledge acquisition and skill development through interactive group activities.
  • It aims to empower patients to actively participate in their care and improve their overall HRQOL.

Conclusions:

  • The developed intervention effectively teaches adherence skills based on a validated theoretical model.
  • A forthcoming randomized trial will evaluate the HCV-SMP's efficacy in enhancing HRQOL among hard-to-reach populations.
  • This program represents a promising approach to supporting chronic hepatitis C patients in managing their health.
Abstract

Related Concept Videos

Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic sinusitis...
Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
Myocarditis IV: Nursing Management01:22

Myocarditis IV: Nursing Management

Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...